{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:40:53Z","timestamp":1794552053722,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060552"],"award-info":[{"award-number":["82060552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202846"],"award-info":[{"award-number":["82202846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011827","name":"Guangxi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["AD22080041"],"award-info":[{"award-number":["AD22080041"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2020GXNSFBA297057"],"award-info":[{"award-number":["2020GXNSFBA297057"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117472","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T05:52:34Z","timestamp":1727329954000},"page":"117472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["FTH1P8 induces and transmits docetaxel resistance by inhibiting ferroptosis in prostate cancer"],"prefix":"10.1016","volume":"180","author":[{"given":"Junhong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanwei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meichun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2024.117472_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.biopha.2024.117472_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000481438","article-title":"Management of biochemical recurrence after primary curative treatment for prostate cancer: a review","volume":"100","author":"Artibani","year":"2018","journal-title":"Urol. Int"},{"issue":"1","key":"10.1016\/j.biopha.2024.117472_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.biopha.2024.117472_bib4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.2017.75.3657","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial","volume":"36","author":"Kyriakopoulos","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117472_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6004\/jnccn.2023.0014","article-title":"NCCN Guidelines\u00ae insights: prostate cancer early detection, version 1.2023","volume":"21","author":"Moses","year":"2023","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.biopha.2024.117472_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114392","article-title":"Paclitaxel and docetaxel resistance in prostate cancer: molecular mechanisms and possible therapeutic strategies","volume":"160","author":"Hashemi","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117472_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188481","article-title":"Mechanisms of docetaxel resistance in prostate cancer: the key role played by miRNAs","volume":"1875","author":"Rizzo","year":"2021","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2024.117472_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2024.117472_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2024.117472_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/med.21933","article-title":"Ferroptosis-modulating small molecules for targeting drug-resistant cancer: challenges and opportunities in manipulating redox signaling","volume":"43","author":"Koeberle","year":"2023","journal-title":"Med Res Rev."},{"key":"10.1016\/j.biopha.2024.117472_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100985","article-title":"Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells","volume":"70","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10.1016\/j.biopha.2024.117472_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ccr.2012.07.016","article-title":"Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells","volume":"22","author":"Domingo-Domenech","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.117472_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13046-018-0894-0","article-title":"FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC","volume":"37","author":"Cao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"W1","key":"10.1016\/j.biopha.2024.117472_bib14","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gkab418","article-title":"GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA","volume":"49","author":"Li","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.biopha.2024.117472_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41588-020-0669-3","article-title":"Guidelines for human gene nomenclature","volume":"52","author":"Bruford","year":"2020","journal-title":"Nat. Genet"},{"key":"10.1016\/j.biopha.2024.117472_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fcell.2020.00085","article-title":"Pseudogene-derived lncRNAs and their miRNA sponging mechanism in human cancer","volume":"8","author":"Lou","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117472_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41419-020-2356-9","article-title":"MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1\/2","volume":"11","author":"Tian","year":"2020","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.biopha.2024.117472_bib18","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3390\/cells9122554","article-title":"FTH1 pseudogenes in cancer and cell metabolism","volume":"9","author":"Di Sanzo","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2024.117472_bib19","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","article-title":"FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson's disease","volume":"17","author":"Tian","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.biopha.2024.117472_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/carcin\/bgad012","article-title":"RSL1D1 knockdown induces ferroptosis and mediates ferrous iron accumulation in senescent cells by inhibiting FTH1 mRNA stability","volume":"44","author":"Jin","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2024.117472_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114048","article-title":"Melatonin inhibits ferroptosis and delays age-related cataract by regulating SIRT6\/p-Nrf2\/GPX4 and SIRT6\/NCOA4\/FTH1 pathways","volume":"157","author":"Mi","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.117472_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.32604\/or.2023.027815","article-title":"LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells","volume":"31","author":"Jin","year":"2023","journal-title":"Oncol. Res"},{"key":"10.1016\/j.biopha.2024.117472_bib23","first-page":"23","article-title":"Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19\/miR-19b-3p\/FTH1 axis","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2024.117472_bib24","doi-asserted-by":"crossref","first-page":"7843863","DOI":"10.1155\/2022\/7843863","article-title":"TUG1\/MAZ\/FTH1 axis attenuates the antiglioma effect of dihydroartemisinin by inhibiting ferroptosis","volume":"2022","author":"Gong","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"14","key":"10.1016\/j.biopha.2024.117472_bib25","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"Pt A","key":"10.1016\/j.biopha.2024.117472_bib26","first-page":"290","article-title":"Mediation of synergistic chemotherapy and gene therapy via nanoparticles based on chitosan and ionic polysaccharides","volume":"223","author":"Zhang","year":"2022","journal-title":"Int J. Biol. Macromol."},{"issue":"Database issue","key":"10.1016\/j.biopha.2024.117472_bib27","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"6472","key":"10.1016\/j.biopha.2024.117472_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117472_bib29","article-title":"Verteporfin exerts anticancer effects and reverses resistance to paclitaxel via inducing ferroptosis in esophageal squamous cell cancer cells","author":"Wang","year":"2023","journal-title":"Mol. Biotechnol."},{"issue":"20","key":"10.1016\/j.biopha.2024.117472_bib30","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1200\/JCO.23.00041","article-title":"Darolutamide plus androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer by disease volume and risk subgroups in the phase III ARASENS trial","volume":"41","author":"Hussain","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.biopha.2024.117472_bib31","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3390\/cells12162046","article-title":"Glucocorticoid receptor regulates and interacts with LEDGF\/p75 to promote docetaxel resistance in prostate cancer cells","volume":"12","author":"Sanchez-Hernandez","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2024.117472_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF00283363","article-title":"Genes for the 'H' subunit of human ferritin are present on a number of human chromosomes","volume":"71","author":"Cragg","year":"1985","journal-title":"Hum. Genet"},{"issue":"1","key":"10.1016\/j.biopha.2024.117472_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-019-0940-3","article-title":"PIWI-interacting RNA-36712 restrains breast cancer progression and chemoresistance by interaction with SEPW1 pseudogene SEPW1P RNA","volume":"18","author":"Tan","year":"2019","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2024.117472_bib34","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117472_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100977","article-title":"Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis","volume":"70","author":"Yu","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"44","key":"10.1016\/j.biopha.2024.117472_bib36","doi-asserted-by":"crossref","first-page":"52374","DOI":"10.1021\/acsami.1c14944","article-title":"Intravesical mucoadhesive hydrogel induces chemoresistant bladder cancer ferroptosis through delivering iron oxide nanoparticles in a three-tier strategy","volume":"13","author":"Qi","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117472_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.biopha.2024.117472_bib38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13046-021-02168-2","article-title":"PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells","volume":"40","author":"You","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117472_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/jacs.2c09139","article-title":"Iron-containing protein-mimic supramolecular iron delivery systems for ferroptosis tumor therapy","volume":"145","author":"Liu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"17","key":"10.1016\/j.biopha.2024.117472_bib40","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1021\/acs.accounts.1c00267","article-title":"Ferritin: a multifunctional nanoplatform for biological detection, imaging diagnosis, and drug delivery","volume":"54","author":"Song","year":"2021","journal-title":"Acc. Chem. Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.117472_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","article-title":"The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2024.117472_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12935-020-01422-5","article-title":"Circ_0000190 suppresses gastric cancer progression potentially via inhibiting miR-1252\/PAK3 pathway","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2024.117472_bib43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.omtn.2019.12.005","article-title":"circCELSR1 (hsa_circ_0063809) contributes to paclitaxel resistance of ovarian cancer cells by regulating FOXR2 expression via miR-1252","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2024.117472_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100960","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2024.117472_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100915","article-title":"Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy","volume":"67","author":"Yu","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"5","key":"10.1016\/j.biopha.2024.117472_bib46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/tox.23159","article-title":"Dysregulated pseudogene BNIP3P1 inhibited cell proliferation and promoted cell apoptosis in preeclampsia by acting as a competing endogenous RNA for BNIP3","volume":"37","author":"Zheng","year":"2022","journal-title":"Environ. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117472_bib47","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/pharmaceutics14050964","article-title":"Development and evaluation of a PSMA-targeted nanosystem co-packaging docetaxel and androgen receptor siRNA for castration-resistant prostate cancer treatment","volume":"14","author":"Zhang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"26","key":"10.1016\/j.biopha.2024.117472_bib48","doi-asserted-by":"crossref","first-page":"11414","DOI":"10.1039\/D1NR02179F","article-title":"Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells","volume":"13","author":"Conte","year":"2021","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.biopha.2024.117472_bib49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00280-012-2048-y","article-title":"A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies","volume":"71","author":"Deeken","year":"2013","journal-title":"Cancer Chemother. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:38:31Z","timestamp":1778693911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224013581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":49,"alternative-id":["S0753332224013581"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117472","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTH1P8 induces and transmits docetaxel resistance by inhibiting ferroptosis in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117472"}}